USANA HEALTH SCIENCES INC (USNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-03. Amounts in USD.

Revenue Quarterly

0 150M 300M 450M Q1 '18: 255.3M Q2 '18: 257.1M Q3 '18: 261.8M Q4 '18: 273.1M Q1 '19: 292M Q2 '19: 301.5M Q3 '19: 296.8M Q4 '19: 299M Q1 '20: 273M Q2 '20: 256M Q3 '20: 260.6M Q4 '20: 271.3M Q1 '21: 266.6M Q2 '21: 259M Q3 '21: 298.5M Q4 '21: 310.5M Q1 '22: 308M Q2 '22: 336.8M Q3 '22: 274.4M Q4 '22: 267.3M Q1 '23: 272.9M Q2 '23: 264.5M Q3 '23: 233.3M Q4 '23: 228M Q1 '24: 248.4M Q2 '24: 238.2M Q3 '24: 213.4M Q4 '24: 221.1M Q1 '25: 227.8M Q2 '25: 212.9M Q3 '25: 200.2M Q4 '25: 213.6M Q1 '26: 249.5M Q2 '26: 235.8M Q3 '26: 213.7M Q4 '26: 226.2M Q1 '27: 250.2M Q2 '27: 223.3M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26 Q2 '27

Gross Profit Quarterly

0 100M 200M 300M Q1 '11: 96.1M Q2 '11: 103.3M Q3 '11: 109.8M Q4 '11: 113M Q1 '12: 117.9M Q2 '12: 122.7M Q3 '12: 118.3M Q4 '12: 121.3M Q1 '13: 126.9M Q2 '13: 132.8M Q3 '13: 134.8M Q4 '13: 138.4M Q1 '14: 138.8M Q2 '14: 157.2M Q3 '14: 142.2M Q4 '14: 152.5M Q1 '15: 148.6M Q2 '15: 153.4M Q3 '15: 157.4M Q4 '15: 190.4M Q1 '16: 181M Q2 '16: 193.2M Q3 '16: 192.2M Q4 '16: 192.4M Q1 '17: 197.5M Q2 '17: 212.5M Q3 '17: 209.2M Q4 '17: 206.6M Q1 '18: 212.7M Q2 '18: 213.2M Q3 '18: 214.6M Q4 '18: 227.4M Q1 '19: 242.6M Q2 '19: 251.5M Q3 '19: 244.9M Q4 '19: 249.6M Q1 '20: 227.1M Q2 '20: 209.5M Q3 '20: 212.8M Q4 '20: 224M Q1 '21: 220.6M Q2 '21: 211.3M Q3 '21: 242.2M Q4 '21: 251.5M Q1 '22: 250.3M Q2 '22: 279.8M Q3 '22: 223.6M Q4 '22: 214.8M Q1 '23: 221.5M Q2 '23: 215M Q3 '23: 186.7M Q4 '23: 181.5M Q1 '24: 199.8M Q2 '24: 194.9M Q3 '24: 170.8M Q4 '24: 178.8M Q1 '25: 184.7M Q2 '25: 172.5M Q3 '25: 161M Q4 '25: 175.1M Q1 '26: 197.1M Q2 '26: 185.7M Q3 '26: 164.9M Q4 '26: 176.8M Q1 '27: 190.8M Q2 '27: 174.9M Q3 '11 Q4 '13 Q1 '16 Q2 '18 Q3 '20 Q4 '22 Q1 '25 Q2 '27

Operating Income Quarterly

-20M 0 20M 40M 60M Q1 '11: 14.5M Q2 '11: 17.1M Q3 '11: 18.5M Q4 '11: 18.1M Q1 '12: 17.2M Q2 '12: 21.2M Q3 '12: 18.8M Q4 '12: 20.1M Q1 '13: 20.9M Q2 '13: 25.2M Q3 '13: 24.1M Q4 '13: 28.1M Q1 '14: 26.6M Q2 '14: 36.5M Q3 '14: 24.7M Q4 '14: 29M Q1 '15: 25.1M Q2 '15: 29.1M Q3 '15: 29.3M Q4 '15: 32.6M Q1 '16: 29.8M Q2 '16: 38.8M Q3 '16: 38M Q4 '16: 35.1M Q1 '17: 33.5M Q2 '17: 37.4M Q3 '17: 35.8M Q4 '17: 31.8M Q1 '18: 32.9M Q2 '18: 32.4M Q3 '18: 31.4M Q4 '18: 35.9M Q1 '19: 43.1M Q2 '19: 51.1M Q3 '19: 45.5M Q4 '19: 48.6M Q1 '20: 35M Q2 '20: 31.2M Q3 '20: 35.5M Q4 '20: 44.6M Q1 '21: 39M Q2 '21: 39.6M Q3 '21: 45.4M Q4 '21: 52.5M Q1 '22: 44.2M Q2 '22: 53.7M Q3 '22: 40.8M Q4 '22: 31.5M Q1 '23: 33.1M Q2 '23: 29.4M Q3 '23: 22.6M Q4 '23: 22.6M Q1 '24: 26.8M Q2 '24: 24.4M Q3 '24: 17.6M Q4 '24: 24.2M Q1 '25: 24.7M Q2 '25: 17.8M Q3 '25: 15.6M Q4 '25: 8.2M Q1 '26: 15.7M Q2 '26: 16.7M Q3 '26: 1.2M Q4 '26: 3.8M Q1 '27: 13.9M Q2 '27: -20M Q3 '11 Q4 '13 Q1 '16 Q2 '18 Q3 '20 Q4 '22 Q1 '25 Q2 '27

Net Income Quarterly

-30M -15M 0 15M 30M 45M Q1 '11: 9.6M Q2 '11: 10.8M Q3 '11: 12.8M Q4 '11: 12.4M Q1 '12: 11.3M Q2 '12: 13.9M Q3 '12: 12.4M Q4 '12: 13.2M Q1 '13: 13.8M Q2 '13: 16.7M Q3 '13: 17.5M Q4 '13: 18.4M Q1 '14: 17.8M Q2 '14: 24.2M Q3 '14: 16.8M Q4 '14: 20.3M Q1 '15: 16.5M Q2 '15: 19.3M Q3 '15: 19.5M Q4 '15: 21.3M Q1 '16: 19.7M Q2 '16: 25.4M Q3 '16: 25.6M Q4 '16: 24M Q1 '17: 22.3M Q2 '17: 25.8M Q3 '17: 30.1M Q4 '17: 21.9M Q1 '18: 21.4M Q2 '18: 23.3M Q3 '18: 23.8M Q4 '18: -5.9M Q1 '19: 28.9M Q2 '19: 33.9M Q3 '19: 31M Q4 '19: 32.3M Q1 '20: 24.2M Q2 '20: 21.4M Q3 '20: 24.2M Q4 '20: 30.8M Q1 '21: 26.6M Q2 '21: 28M Q3 '21: 30.5M Q4 '21: 39.6M Q1 '22: 30.6M Q2 '22: 38.2M Q2 '22: 38.2M Q3 '22: 27.3M Q4 '22: 20.3M Q1 '23: 22.5M Q2 '23: 19.2M Q3 '23: 14.9M Q4 '23: 12.8M Q1 '24: 18.4M Q2 '24: 17.3M Q3 '24: 11.3M Q4 '24: 16.8M Q1 '25: 16.5M Q2 '25: 10.4M Q3 '25: 10.6M Q4 '25: 4.5M Q1 '26: 9.4M Q2 '26: 9.7M Q3 '26: -6.5M Q4 '26: -1.8M Q1 '27: 7.5M Q2 '27: -21.4M Q4 '11 Q1 '14 Q2 '16 Q3 '18 Q4 '20 Q4 '22 Q1 '25 Q2 '27

Cost of Revenue Quarterly

0 25M 50M 75M Q3 '18: 47.1M Q4 '18: 45.7M Q1 '19: 49.4M Q2 '19: 50M Q3 '19: 51.9M Q4 '19: 49.5M Q1 '20: 45.9M Q2 '20: 46.5M Q3 '20: 47.8M Q4 '20: 47.3M Q1 '21: 46.1M Q2 '21: 47.7M Q3 '21: 56.4M Q4 '21: 59M Q1 '22: 57.7M Q2 '22: 57M Q3 '22: 50.7M Q4 '22: 52.5M Q1 '23: 51.4M Q2 '23: 49.5M Q3 '23: 46.6M Q4 '23: 46.4M Q1 '24: 48.5M Q2 '24: 43.3M Q3 '24: 42.5M Q4 '24: 42.3M Q1 '25: 43.1M Q2 '25: 40.3M Q3 '25: 39.3M Q4 '25: 38.6M Q1 '26: 52.4M Q2 '26: 50.2M Q3 '26: 48.8M Q4 '26: 49.4M Q1 '27: 59.4M Q2 '27: 48.3M Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q4 '24 Q1 '26 Q2 '27

Operating Cash Flow Quarterly

-20M 0 20M 40M 60M Q3 '11: 20.9M Q4 '11: 19.9M Q1 '12: 17.5M Q2 '12: 13.9M Q3 '12: 22.1M Q4 '12: 16.6M Q1 '13: 22.6M Q2 '13: 21.3M Q3 '13: 19.7M Q4 '13: 29.2M Q1 '14: 20.3M Q2 '14: 27M Q3 '14: 17.3M Q4 '14: 34.3M Q1 '15: 2.5M Q2 '15: 28.8M Q3 '15: 36.1M Q4 '15: 37.8M Q1 '16: 23.6M Q2 '16: 22.6M Q3 '16: 28.4M Q4 '16: 36.9M Q1 '17: 13.5M Q2 '17: 34.5M Q3 '17: 33.8M Q4 '17: 55.3M Q1 '18: 1.9M Q2 '18: 53.7M Q3 '18: 13M Q4 '18: 55.1M Q1 '19: 19.5M Q2 '19: 37.7M Q3 '19: 54.5M Q4 '19: 40.4M Q1 '20: 5.5M Q2 '20: 15.2M Q3 '20: 50.3M Q4 '20: 55.7M Q1 '21: 30.8M Q2 '21: 32.6M Q3 '21: 49.1M Q4 '21: 47.9M Q1 '22: 19.7M Q2 '22: 39.2M Q3 '22: 37.5M Q4 '22: 24.9M Q1 '23: 19.7M Q2 '23: 14.6M Q3 '23: 29.1M Q4 '23: 40.5M Q1 '24: 12.8M Q2 '24: 9.6M Q3 '24: 22.2M Q4 '24: 26M Q1 '25: 17.7M Q2 '25: 8M Q3 '25: 29.5M Q4 '25: 5.8M Q1 '26: 15.5M Q2 '26: 12.2M Q3 '26: -2M Q4 '26: -3.4M Q1 '27: 9.8M Q2 '27: 23.3M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Free Cash Flow Quarterly

-20M 0 20M 40M 60M Q3 '11: 20.9M Q4 '11: 19.4M Q1 '12: 16.9M Q2 '12: 8.7M Q3 '12: 19.3M Q4 '12: 14.6M Q1 '13: 20.4M Q2 '13: 20.1M Q3 '13: 16.3M Q4 '13: 27.6M Q1 '14: 19.4M Q2 '14: 24.9M Q3 '14: 14M Q4 '14: 32.6M Q1 '15: 1.5M Q2 '15: 19.7M Q3 '15: 33M Q4 '15: 30.6M Q1 '16: 17.7M Q2 '16: 18.7M Q3 '16: 21.7M Q4 '16: 29.7M Q1 '17: 4.5M Q2 '17: 29.8M Q3 '17: 21.4M Q4 '17: 48.6M Q1 '18: -1.5M Q2 '18: 50.1M Q3 '18: 10.8M Q4 '18: 51.1M Q1 '19: 16.6M Q2 '19: 34M Q3 '19: 52.3M Q4 '19: 37.9M Q1 '20: 2.9M Q2 '20: 10.6M Q3 '20: 46.1M Q4 '20: 50.5M Q1 '21: 23.5M Q2 '21: 29.1M Q3 '21: 46.3M Q4 '21: 46.4M Q1 '22: 18.1M Q2 '22: 37.6M Q3 '22: 31M Q4 '22: 21.8M Q1 '23: 17.9M Q2 '23: 12.9M Q3 '23: 25.5M Q4 '23: 37.2M Q1 '24: 10.7M Q2 '24: 5.9M Q3 '24: 20.8M Q4 '24: 18.7M Q1 '25: 14.5M Q2 '25: 5.3M Q3 '25: 27.1M Q4 '25: 4M Q1 '26: 12.7M Q2 '26: 7.2M Q3 '26: -5.2M Q4 '26: -6.2M Q1 '27: 7.1M Q2 '27: 20.2M Q2 '13 Q2 '15 Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25 Q2 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '11: 15.7M Q3 '11: 16.2M Q1 '12: 16.2M Q2 '12: 15.8M Q3 '12: 15.2M Q1 '13: 15.3M Q2 '13: 15.1M Q3 '13: 14.9M Q1 '14: 13.9M Q2 '14: 14.1M Q3 '14: 14.4M Q1 '15: 14.4M Q2 '15: 14.2M Q3 '15: 13.3M Q1 '16: 13.1M Q2 '16: 13.2M Q3 '16: 13.3M Q1 '17: 25.2M Q2 '17: 24.9M Q3 '17: 25.1M Q1 '18: 25M Q2 '18: 25M Q3 '18: 24.6M Q1 '19: 24.3M Q2 '19: 24.8M Q3 '19: 25M Q1 '20: 23.9M Q2 '20: 23.4M Q3 '20: 22.2M Q1 '21: 21.6M Q2 '21: 21.1M Q3 '21: 21.2M Q1 '22: 21.1M Q2 '22: 20.4M Q2 '22: 20.4M Q3 '22: 20.2M Q1 '23: 19.5M Q2 '23: 19.2M Q3 '23: 19.3M Q1 '24: 19.3M Q2 '24: 19.4M Q3 '24: 19.4M Q1 '25: 19.3M Q2 '25: 19.2M Q3 '25: 19.1M Q1 '26: 19.1M Q2 '26: 18.5M Q3 '26: 18.3M Q1 '27: 18.4M Q2 '27: 18.5M Q2 '11 Q3 '13 Q1 '16 Q2 '18 Q3 '20 Q3 '22 Q1 '25 Q2 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.50 0.00 2.50 5.00 7.50 Q4 '11: 2.86 Q1 '12: 2.93 Q2 '12: 3.12 Q3 '12: 3.14 Q4 '12: 3.26 Q1 '13: 3.46 Q2 '13: 3.69 Q3 '13: 4.06 Q4 '13: 4.46 Q1 '14: 4.84 Q2 '14: 5.45 Q3 '14: 5.43 Q4 '14: 5.57 Q1 '15: 5.44 Q2 '15: 5.08 Q3 '15: 5.39 Q4 '15: 5.63 Q1 '16: 5.98 Q2 '16: 6.54 Q3 '16: 6.99 Q4 '16: 6.26 Q1 '17: 5.65 Q2 '17: 4.76 Q3 '17: 4.04 Q4 '17: 3.99 Q1 '18: 3.96 Q2 '18: 3.86 Q3 '18: 3.63 Q4 '18: 2.52 Q1 '19: 2.85 Q2 '19: 3.28 Q3 '19: 3.55 Q4 '19: 5.11 Q1 '20: 4.93 Q2 '20: 4.48 Q3 '20: 4.33 Q4 '20: 4.42 Q1 '21: 4.64 Q2 '21: 5.05 Q3 '21: 5.40 Q4 '21: 5.85 Q1 '22: 6.07 Q1 '23: 5.43 Q2 '23: 4.56 Q3 '23: 3.98 Q4 '23: 3.59 Q1 '24: 3.39 Q2 '24: 3.28 Q3 '24: 3.09 Q4 '24: 3.30 Q1 '25: 3.21 Q2 '25: 2.86 Q3 '25: 2.83 Q4 '25: 2.19 Q1 '26: 1.82 Q2 '26: 1.80 Q3 '26: 0.88 Q4 '26: 0.58 Q1 '27: 0.50 Q2 '27: -1.18 Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q2 '23 Q2 '25 Q2 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.